Asahi Kasei Partners With Circularise, Furuya Metal on Precious Metal Traceability ProjectPUBT·Nov 12, 2026 at 01:34 PMAHKSY+0.34%3407
Asahi Kasei: Higher earnings and revised FY2026 guidance, amid softer operating cash flowQuartr·Nov 5, 2026 at 03:30 AMAHKSY+0.34%3407
Toppan Holdings Joins Five Companies to Develop Quantum Computing-Based Materials PlatformPUBT·Oct 28, 2026 at 01:10 AMAHKSY+0.34%SFTBY-7.12%
AGC Joins Five Partners to Develop Quantum Computing-Based Materials PlatformPUBT·Oct 28, 2026 at 01:05 AM5201
Asahi Kasei Subsidiary Secures Independent Verification of Acrylonitrile Carbon FootprintPUBT·Oct 20, 2026 at 12:30 PMAHKSY+0.34%3407
FDA approves Asahi Kasei’s Hovilpri for refractory HSVPharmaceutical Technology·Oct 12, 2026 at 10:04 AMAHKSY+0.34%3407
Goldman Sachs downgrades Asahi Kasei (AHKSF) to a HoldTip Ranks·Oct 12, 2026 at 05:55 AMAHKSY+0.34%3407
Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults | AHKSY Stock NewsStockTitan·Oct 9, 2026 at 02:41 PMAHKSY+0.34%3407
